Lobbying

Wellcome Trust tells WHO it opposes R&D Treaty and the de-linkage of R&D costs from drug prices

Posted on by Thiru

At WHO deliberations (26 November 2012 to 28 November 2012) on charting a path forward following the recommendations of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), Bolivia, Colombia and Thailand reiterated their political commitment supporting a binding R&D treaty. Continue Reading →

Update: Global Fund responds to Report on William Steiger

Posted on by Thiru

The Global Fund just sent an email, which says that “your website which inaccurately reports that Mr Steiger will run VPP.” Here is the Global Fund email:

From: Andrew Hurst
Date: June 20, 2012 5:36:49 PM GMT+02:00
To: Thirukumaran Balasubramaniam Subject: RE: Question on the Global Fund’s Voluntary Pooled Procurement?

Dear Thiru

Further to our conversation this week, here is our statement:

Continue Reading →

Response of WHO to KEI letter regarding McKinsey, vaccine policy and competing interests

Posted on by Thiru

On 20 February 2011, Dr. Keiji Fukuda, Assistant Director-General – Health Security and Environment, World Health Organization, responded to KEI’s letter (16 February 2011) regarding McKinsey, vaccine policy and competing interests. Here is the response in full (email contacts have been redacted).

From: “Fukuda, Keiji”
Date: February 20, 2011 4:14:05 PM GMT+01:00
To: “Thiru Balasubramaniam”
Continue Reading →